Introduction to molecular cystic fibrosis testing

Area of Science:

• Medical Diagnostics
• Molecular Genetics
• Clinical Laboratory Science

Background:

• Advancements in technology are integrating molecular diagnostics into routine laboratory practices.
• The American College of Medical Genetics and Genomics (ACMG) released recommendations for cystic fibrosis carrier testing, increasing demand and commercial test kit development.
• Laboratories with limited molecular genetics experience may face challenges with genetic disease testing.

Purpose of the Study:

• To provide an overview of cystic fibrosis (CF) testing for laboratories.
• To discuss key aspects of molecular testing for CF, including disease overview, mutation testing, and quality assurance.
• To address challenges and considerations for implementing CF molecular diagnostics in routine settings.

Main Methods:

• Review of cystic fibrosis disease pathology and genetic basis.
• Discussion of current mutation detection methodologies for CF.
• Examination of quality assurance and reporting standards for molecular genetic testing.

Main Results:

• Increased adoption of molecular diagnostics in clinical labs.
• Development of commercial test kits and rising volumes for CF carrier testing.
• Identification of specific challenges in CF mutation testing, quality control, and result reporting.

Conclusions:

• Molecular testing for genetic diseases like cystic fibrosis requires specialized knowledge and infrastructure.
• Adherence to quality assurance and standardized reporting is crucial for accurate CF diagnostic testing.
• Laboratories need to prepare for the integration of advanced molecular diagnostics for genetic conditions.